MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report.

Rihawi K, Alfieri R, Fiorentino M, Fontana F, Capizzi E, Cavazzoni A, Terracciano M, La Monica S, Ferrarini A, Buson G, Petronini PG, Ardizzoni A.

Open source

DOI: 10.1016/j.tranon.2018.09.013
Published: 2018-10-02
Container: Transl Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.tranon.2018.09.013,
  title = {MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report.},
  author = {Rihawi K and  Alfieri R and  Fiorentino M and  Fontana F and  Capizzi E and  Cavazzoni A and  Terracciano M and  La Monica S and  Ferrarini A and  Buson G and  Petronini PG and  Ardizzoni A.},
  year = {2019},
  journal = {Transl Oncol},
  doi = {10.1016/j.tranon.2018.09.013},
  url = {https://doi.org/10.1016/j.tranon.2018.09.013}
}

RIS

TY  - JOUR
TI  - MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report.
AU  - Rihawi K
AU  -  Alfieri R
AU  -  Fiorentino M
AU  -  Fontana F
AU  -  Capizzi E
AU  -  Cavazzoni A
AU  -  Terracciano M
AU  -  La Monica S
AU  -  Ferrarini A
AU  -  Buson G
AU  -  Petronini PG
AU  -  Ardizzoni A.
PY  - 2019
JO  - Transl Oncol
DO  - 10.1016/j.tranon.2018.09.013
UR  - https://doi.org/10.1016/j.tranon.2018.09.013
ER  -

APA

K, R., R, A., M, F., F, F., E, C., A, C., M, T., S, L. M., A, F., G, B., PG, P., & A., A. (2019). MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report.. Transl Oncol. https://doi.org/10.1016/j.tranon.2018.09.013

Source records

europe-pmc · retrieved 2026-09-27T15:50:23.487Z